

1,401,972 filings since 2004 · latest accepted Nov 4, 2026, 6:48 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Dec 18, 2025 accepted 5:21 PM ET | TVRDTvardi Therapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 14, 2025 accepted 5:00 PM ET | TVRDTvardi Therapeutics, Inc. | Officer / director change |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Apr 15, 2025 accepted 4:06 PM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement2.01Acquisition / disposition3.03Holder rights modified5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year5.05Code of ethics5.06Shell status change7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Dec 18, 2024 accepted 7:23 AM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement5.01Change in control5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Mar 22, 2024 accepted 4:05 PM ET | TVRDTvardi Therapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 3, 2023 accepted 7:06 AM ET | TVRDTvardi Therapeutics, Inc. | 5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 3, 2022 accepted 7:12 AM ET | TVRDTvardi Therapeutics, Inc. | 5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 12, 2022 accepted 6:01 AM ET | TVRDTvardi Therapeutics, Inc. | 5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Jun 3, 2022 accepted 4:30 PM ET | TVRDTvardi Therapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 21, 2021 accepted 4:30 PM ET | TVRDTvardi Therapeutics, Inc. | 5.02Officer / director change | DocumentSEC ↗ |